Page last updated: 2024-08-23

pirfenidone and Fatigue

pirfenidone has been researched along with Fatigue in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Antoniou, K; Kamekis, A; Kokosi, M; Swigris, JJ; Symvoulakis, EK1
Arlandis, M; Aznar, T; Chiner, E; Herraiz, P; Marcos Ribes, B; Sancho-Chust, JN; Talens, A1
Ehlers-Tenenbaum, S; Herth, FJ; Heussel, CP; Kahn, N; Kreuter, M; Oltmanns, U; Palmowski, K; Puderbach, M; Schnabel, PA; Träger, A; Warth, A; Wenz, H; Wiebel, M1

Reviews

1 review(s) available for pirfenidone and Fatigue

ArticleYear
Burden of idiopathic pulmonary fibrosis on patients' emotional well being and quality of life: a literature review.
    Current opinion in pulmonary medicine, 2020, Volume: 26, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cough; Dyspnea; Fatigue; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Mental Health; Protein Kinase Inhibitors; Pyridones; Quality of Life

2020

Other Studies

2 other study(ies) available for pirfenidone and Fatigue

ArticleYear
Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis.
    European journal of hospital pharmacy : science and practice, 2020, Volume: 27, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Exercise Test; Fatigue; Female; Follow-Up Studies; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Myalgia; Pyridones; Retrospective Studies; Treatment Outcome

2020
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
    Respiration; international review of thoracic diseases, 2014, Volume: 88, Issue:3

    Topics: Acetylcysteine; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Disease Progression; Drug Eruptions; Drug Therapy, Combination; Expectorants; Fatigue; Female; Gastrointestinal Diseases; Germany; Humans; Idiopathic Pulmonary Fibrosis; Male; Medication Adherence; Middle Aged; Pyridones; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Vital Capacity; Weight Loss

2014